Found: 39
Select item for more details and to access through your institution.
Outcomes and chemotherapy-related toxicity in HIV-infected patients with breast cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Pathologic Complete Response to Preoperative Sequential Doxorubicin/Cyclophosphamide and Single-Agent Taxane With or Without Trastuzumab in Stage II/III HER2-Positive Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 1, p. 40, doi. 10.3816/CBC.2010.n.005
- By:
- Publication type:
- Article
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37806-0
- By:
- Publication type:
- Article
Next generation of immune checkpoint therapy in cancer: new developments and challenges.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, p. 1, doi. 10.1186/s13045-018-0582-8
- By:
- Publication type:
- Article
Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7299, doi. 10.3390/ijms23137299
- By:
- Publication type:
- Article
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 3, p. 497, doi. 10.1007/s10549-023-07159-9
- By:
- Publication type:
- Article
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 1, p. 103, doi. 10.1007/s10549-019-05284-y
- By:
- Publication type:
- Article
Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1235902
- By:
- Publication type:
- Article
Increasing National Mastectomy Rates for the Treatment of Early Stage Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 5, p. 1436, doi. 10.1245/s10434-012-2732-5
- By:
- Publication type:
- Article
Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity.
- Published in:
- Clinical & Experimental Metastasis, 2008, v. 25, n. 5, p. 549, doi. 10.1007/s10585-008-9169-z
- By:
- Publication type:
- Article
Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer.
- Published in:
- Breast Cancer: Targets & Therapy, 2015, v. 7, p. 321, doi. 10.2147/BCTT.S90627
- By:
- Publication type:
- Article
CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostim.
- Published in:
- 2013
- By:
- Publication type:
- Letter
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00452-8
- By:
- Publication type:
- Article
Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00430-0
- By:
- Publication type:
- Article
Exploring the Biological and Physical Basis of Boron Neutron Capture Therapy (BNCT) as a Promising Treatment Frontier in Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 3009, doi. 10.3390/cancers14123009
- By:
- Publication type:
- Article
Cytometric characterization of Circulating Tumor Cells Captured by microfiltration and their correlation to the cellsearch<sup>®</sup> CTC test.
- Published in:
- Cytometry. Part A, 2015, v. 87, n. 2, p. 137, doi. 10.1002/cyto.a.22613
- By:
- Publication type:
- Article
Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 3, p. 499, doi. 10.1007/s10549-015-3442-z
- By:
- Publication type:
- Article
Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade involving galectin-3, α9 nicotinic acetylcholine receptor and STAT3.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 145, n. 1, p. 5, doi. 10.1007/s10549-014-2912-z
- By:
- Publication type:
- Article
A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 138, n. 1, p. 167, doi. 10.1007/s10549-013-2427-z
- By:
- Publication type:
- Article
The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 135, n. 3, p. 681, doi. 10.1007/s10549-012-2148-8
- By:
- Publication type:
- Article
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1224702
- By:
- Publication type:
- Article
Aromatase inhibitors and breast cancer.
- Published in:
- Hormone Molecular Biology & Clinical Investigation, 2012, v. 9, n. 2, p. 119, doi. 10.1515/hmbci-2012-0001
- By:
- Publication type:
- Article
Extending aromatase inhibitor sensitivity in hormone resistant breast cancer.
- Published in:
- Hormone Molecular Biology & Clinical Investigation, 2011, v. 5, n. 2, p. 97, doi. 10.1515/HMBCI.2011.010
- By:
- Publication type:
- Article
Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 1, p. 1, doi. 10.1186/bcr3609
- By:
- Publication type:
- Article
Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells.
- Published in:
- Journal of Cellular Biochemistry, 2015, v. 116, n. 10, p. 2210, doi. 10.1002/jcb.25171
- By:
- Publication type:
- Article
High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 6, p. 334, doi. 10.1159/000477797
- By:
- Publication type:
- Article
Rifaximin for Pertuzumab-Related GI Toxicities.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00168
- By:
- Publication type:
- Article
Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study.
- Published in:
- Diagnostic Pathology, 2007, v. 2, p. 42, doi. 10.1186/1746-1596-2-42
- By:
- Publication type:
- Article
Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients.
- Published in:
- Annals of Nuclear Medicine, 2021, v. 35, n. 11, p. 1264, doi. 10.1007/s12149-021-01675-8
- By:
- Publication type:
- Article
Transfusion medicine illustrated: centrolobular lung edema in probable transfusion-related acute lung injury.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Centrolobular lung edema in probable transfusion-related acute lung injury.
- Published in:
- 2007
- By:
- Publication type:
- Other
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 3, p. 381, doi. 10.1002/cncr.28352
- By:
- Publication type:
- Article
Clinical utilities of aromatase inhibitors in breast cancer.
- Published in:
- International Journal of Women's Health, 2015, v. 7, p. 493, doi. 10.2147/IJWH.S69907
- By:
- Publication type:
- Article